Sarepta's $401 Million Quarter Anchors Healthcare Gains as Volatility and Inflation ETFs PivotGlobal Report·1 day ago, 05:12 AMSRTA+4.70%BMEZ+0.41%
Givaudan SA (OTCMKTS:GVDNY) Sees Significant Decrease in Short InterestMarket Beat·Aug 11 at 10:40 PMGVDNY+0.79%
Market Miscellany Overhaul: Robotics SPAC Mergers and Biotech NDA SubmissionsGlobal Report·Jul 28 at 04:12 AMCCXI+3.55%MNPR-2.85%
Orr Reiterates Hold on Givaudan as Strong Top-Line Momentum Is Offset by Weaker Cash Generation and Margin PressureTip Ranks·Jul 23 at 07:26 AMGVDNY+0.79%
Givaudan H1 Profit, Sales Down; Backs LFL Sales Growth View Aheadrttnews·Jul 23 at 12:08 AMGVDNY+0.79%
GIVN: Solid LFL sales growth and resilient margins, but profits and cash flow declined amid higher costsQuartr·Jul 23 at 12:06 AMGVDNY+0.79%
03:19 ETHerb & Spice Extracts Market Outlook 2036 with Key Contributions from Givaudan, Kerry Group, McCormick & Company, Sensient Technologies, and Symriseprnewswire·Apr 29 at 02:20 AMKRYAY+1.64%GVDNY+0.79%
